참고문헌
- Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21: 538-582. https://doi.org/10.1128/CMR.00058-07
- Kempf M, Rolain J. 2012. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe : Clinical impact and therapeutic options. Int. J. Antimicrob. Agents 39: 105-114. https://doi.org/10.1016/j.ijantimicag.2011.10.004
- Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46: 1254-1263. https://doi.org/10.1086/529198
- Shete VB, Ghadage DP, Muley VA, Bhore AV. 2010. Multi-drug resistant Acinetobacter ventilator-associated pneumonia. Lung India 27: 217-220. https://doi.org/10.4103/0970-2113.71952
- Manageiro V, Jones-Dias D, Ferreira E, Louro D. 2012. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118. Int. J. Antimicrob. Agents 40: 398-403. https://doi.org/10.1016/j.ijantimicag.2012.06.013
- Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumanni. Antimicrob. Agents Chemother. 51: 3471-3484. https://doi.org/10.1128/AAC.01464-06
- Lee H, Chen C, Wang S, Su L, Chen S, Liu S, et al. 2011. Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii : mechanism and clinical implications. Int. J. Antimicrob. Agents 37: 302-308. https://doi.org/10.1016/j.ijantimicag.2010.12.015
- Turton JF, Woodford N, Glover J, Yarde S. 2006. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44: 2974-2976. https://doi.org/10.1128/JCM.01021-06
- Lob SH, Hoban DJ, Sahm DF, Badal RE. 2016. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int. J. Antimicrob. Agents 47: 317-323. https://doi.org/10.1016/j.ijantimicag.2016.01.015
- Morfin-otero R, Dowzicky MJ. 2012. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the tigecycline evaluation and surveillance trial, 2004 to 2009. Clin. Ther. 34: 101-112. https://doi.org/10.1016/j.clinthera.2011.11.028
- Rynga D, Shariff M, Deb M. 2015. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann. Clin. Microbiol. Antimicrob. 14: 40. https://doi.org/10.1186/s12941-015-0101-5
- Nasr RA, Attalah MF. 2012. Molecular epidemiology of nosocomial Acinetobacter baumannii isolates. Nat. Sci. 10: 76-82.
- Bart A, Schuurman IGA, Achtman M, Caugant DA, Dankert J, Ende A. 1998. Randomly amplified polymorphic DNA genotyping of serogroup a meningococci yields results similar to those obtained by multilocus enzyme electrophoresis and reveals new genotypes. J. Clin. Microbiol. 36: 1746-1749. https://doi.org/10.1128/JCM.36.6.1746-1749.1998
- Leal NC, Sobreira M, Leal-Balbino TC, Almeida AMP De, de Silva MJ, Mello DM, et al. 2004. Evaluation of a RAPD-based typing scheme in a molecular epidemiology study of Vibrio cholerae O1, Brazil. J. Appl. Microbiol. 96: 447-454. https://doi.org/10.1111/j.1365-2672.2004.02090.x
- Constantiniu S, Romaniuc A, Iancu LS, Filimon R. 2004. Cultural and biochemical characteristics of Acinetobacter spp. strains isolated from hospital units. J. Prev. Med. 12: 35-42.
- Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27: 351-353. https://doi.org/10.1016/j.ijantimicag.2006.01.004
- Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. 2017. Co-existence of blaOXA-23and blaNDM-1genes of Acinetobacter baumannii isolated from Nepal: Antimicrobial resistance and clinical significance. Antimicrob. Resist. Infect. Control 6: 21. https://doi.org/10.1186/s13756-017-0180-5
- Clinical Laboratory Standards Institute(CLSI). 2019. Performance standards for antimicrobial susceptibility testing. Clin. Lab Stand Inst. 29th ed., pp. 1-319.
- Manchanda V, Sinha S, Singh N. 2010. Multidrug resistant Acinetobacter. J. Glob Infect. Dis. 2: 291-304. https://doi.org/10.4103/0974-777X.68538
- Graser Y, Klare I, Halle E, Gantenberg R, Buchholz P, Jacobi HD, et al. 1993. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J. Clin. Microbiol. 31: 2417-2420. https://doi.org/10.1128/jcm.31.9.2417-2420.1993
- Karthika RU, Rao RS, Sahoo S, Shashikala P, Kanungo R, Jayachandran S, et al. 2009. Phenotypic and genotypic assays for detecting the prevalence of metallo-b-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J. Med. Microbiol. 58: 430-435. https://doi.org/10.1099/jmm.0.002105-0
- Bassetti M, Righi E, Esposito S, Petrosillo N, Nicolini L. 2008. Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol. 3: 649-660. https://doi.org/10.2217/17460913.3.6.649
- Bonomo RA, Szabo D. 2006. Mechanisms of multidrug resistance in Acinetobacter Species and Pseudomonas aeruginosa. Clin. Infect. Dis. 43: S49-S56. https://doi.org/10.1086/504477
- Bonnin RA, Nordmann P, Poirel L. 2013. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: A state of the art. Expert Rev. Anti. Infect. Ther. 11: 571-583. https://doi.org/10.1586/eri.13.38
- Abdulzahra AT, Khalil MAF, Elkhatib WF. 2018. First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt. New Microbes New Infect. 26: 53-58. https://doi.org/10.1016/j.nmni.2018.08.007
- Sadeghifard N, Ranjbar R, Zaeimi J, Alikhanid MY, Ghafouryana S, Raftarie M, et al. 2010. Antimicrobial susceptibility, plasmid profiles, and RAPD-PCR typing of Acinetobacter bacteria. Asian Biomed. 4: 901-911. https://doi.org/10.2478/abm-2010-0118
- Shehta H, Abdalbagi S, Benmahmod B, Hassan R. 2018. Coproduction of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World J. Microbiol. Biotechnol. 34: 189. https://doi.org/10.1007/s11274-018-2571-z
- Azizi O, Shahcheraghi F, Salimizand H, Modaresi F. 2016. Molecular analysis and expression of bap gene in biofilm-forming multidrug-resistant Acinetobacter baumannii. reports. Biochem. Mol. Biol. 5: 62-72.
- Petrova AP, Stanimirova ID, Ivanov IN, Petrov MM, MitevaKatrandzhieva TM, Grivnev VI, et al. 2017. Carbapenemase production of clinical isolates Acinetobacter baumannii and Pseudomonas aeruginosa from a Bulgarian University Hospital. Folia Med. (Plovdiv) 59: 413-422. https://doi.org/10.1515/folmed-2017-0060
- Nwadike, Ugochukwu V, Kingsley C, Iche E. 2014. Multidrug resistant Acinetobacter infection and their antimicrobial susceptibility pattern in a Nigerian Tertiary Hospital ICU. J. Infect. Dis. 8: 14-18.
- Eftekhar F, Torkanpoory NE. 2018. Contribution of contaminated environmental surfaces to the transmission of multidrug-resistant Acinetobacter baumannii in special care units of a hospital in Tehran, Iran. J. Med. Microbiol. Infect. Dis. 6: 37-42.
- Lean S, Suhaili Z, Ismail S, Rahman NIA, Othman N, Abdullah FH, et al. 2014. Prevalence and genetic characterization of carbapenem- and polymyxin-resistant Acinetobacter baumannii isolated from a tertiary hospital in terengganu, Malaysia. ISRN Microbiol. 2014: 953417. https://doi.org/10.1155/2014/953417
- Fouad M, Attia AS, Tawakkol WM, Hashem AM. 2013. Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals. Int. J. Infect. Dis. 17: e1252-e1254. https://doi.org/10.1016/j.ijid.2013.07.012
- Erturk A, Cicek AC, Gumu A, Cure E, Ahmet S, Kurt A, et al. 2014. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann. Clin. Microbiol. Antimicrob. 13: 36. https://doi.org/10.1186/s12941-014-0036-2
- Pogue JM, Mann T, Barber KE, Kaye KS. 2013. Carbapenem-resistant Acinetobacter baumannii: Epidemiology, surveillance and management. Expert Rev. Anti. Infect. Ther. 11: 383-393. https://doi.org/10.1586/eri.13.14
- Evans BA, Amyes SGB. 2014. OXA beta-Lactamases. Clin. Microbiol. Rev. 27: 241-263. https://doi.org/10.1128/CMR.00117-13
- Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. 2014. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int. J. Infect. Dis. 22: 49-54. https://doi.org/10.1016/j.ijid.2013.12.004
- Hamouda A, Evans BA, Towner KJ, Amyes SGB. 2010. Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla OXA-51-like genes. J. Clin. Microbiol. 48: 2476-2483. https://doi.org/10.1128/JCM.02431-09
- Touati M, Diene SM, Racherache A, Dekhil M, Djahoudi A, Rolain JM. 2012. Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int. J. Antimicrob. Agents 40: 84-93. https://doi.org/10.1016/j.ijantimicag.2012.03.011
- Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY. 2013. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev. Anti. Infect. Ther. 11: 395-409. https://doi.org/10.1586/eri.13.21
- Merino Ma, Poza M, Roca I. 2014. Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain. Microb. Drug Resist. 20: 259-263. https://doi.org/10.1089/mdr.2013.0127
- Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R, et al. 2014. Outbreak of multidrug-resistant Acinetobacter baumannii in an intensive care unit. New Microbiol. 37: 185-191.
- Perez F, Endimiani A, Ray AJ, Decker BK, Wallace CJ, Hujer KM, et al. 2010. Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system : impact of postacute care facilities on dissemination. J. Antimicrob. Chemother. 65: 1807-1818. https://doi.org/10.1093/jac/dkq191
- Farshadzadeh Z, Hashemi FB, Rahimi S, Pourakbari B. 2015. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front. Microbiol. 6: 1146. https://doi.org/10.3389/fmicb.2015.01146
- Vali L, Dashti K, Opazo-capurro AF, Dashti AA, Al Obaid K, Evans BA. 2015. Diversity of multi-drug resistant Acinetobacter baumannii population in a major hospital in Kuwait. Front. Immunol. 6: 743.
- Lopes BS, Al-agamy MH, Ismail MA, Shibl AM, Al-Qahtani AA, AlAhdal MN, et al. 2015. The transferability of blaOXA-23 gene in multidrug-resistant Acinetobacter baumannii isolates from Saudi Arabia and Egypt. Int. J. Med. Microbiol. 305: 581-588. https://doi.org/10.1016/j.ijmm.2015.07.007
- Zowawi HM, Sartor AL, Sidjabat HE, Balkhy HH, Walsh TR, Al Johani SM, et al. 2015. Molecular epidemiology of carbapenemresistant Acinetobacter baumannii isolates in the gulf cooperation council states : Dominance of OXA-23-Type producers. J. Clin. Microbiol. 53: 896-903. https://doi.org/10.1128/JCM.02784-14
- Ranjbar R, Zayeri S, Afshar D, Farshad S. 2019. Detection of OXA beta lactamases among clinical isolates of Acinetobacter baumannii isolated from Tehran hospitals, Iran. Open Microbiol. J. 13: 68-72. https://doi.org/10.2174/1874285801913010068
- Handal R, Qunibi L, Sahouri I, Juhari M, Dawodi R, Marzouqa H, et al. 2017. Characterization of carbapenem-resistant Acinetobacter baumannii strains isolated from hospitalized patients in palestine. Int. J. Microbiol. 2017: 8012104.
- Chang Y, Luan G, Xu Y, Wang Y. 2015. Characterization of carbapenem-resistant Acinetobacter baumannii isolates in a Chinese teaching hospital. Front. Microbiol. 6: 690.
- Bannah AMS El, Nawar NN, Hassan RMM, Salem STB. 2017. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Egypt : clonal spread of bla OXA-23. Microb. Drug Resist. 24: 269-277. https://doi.org/10.1089/mdr.2017.0057
- Al Atrouni A, Hamze M, Jisr T, Limarie C, Eveillard M, Joly-Guillou M, et al. 2016. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int. J. Infect. Dis. 52: 29-36. https://doi.org/10.1016/j.ijid.2016.09.017
- Pujol C, Joly S, Lockhart SR, Noel S, Tibayrenc M, Soll DR. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme dlectrophoresis, and southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35: 2348-2358. https://doi.org/10.1128/jcm.35.9.2348-2358.1997
- Li X, Xie Y, Wang M, Xia X, Wang M, Cao W, et al. 2016. Phenotypic and genomic diversity in Acinetobacter baumannii stains random isolated from 2008 to 2012 in a teaching hospital in Hunan, China. Int. J. Clin. Exp. Pathol. 9: 7030-7039.
- Kanj SS, Tayyar R, Shehab M, El-Hafi B, Rasheed SS, Kissoyan KAB, et al. 2018. Increased bla OXA-23-like prevalence in Acinetobacter baumannii at a tertiary care center in Lebanon (2007-2013). J. Infect. Dev. Ctries 12: 228-234. https://doi.org/10.3855/jidc.9642
- Novovic K, Mihajlovic S, Vasiljevic Z, Filipic B. 2015. Carbapenemresistant Acinetobacter baumannii from Serbia : Revision of CarO classification. PLoS One 10: e0122793. https://doi.org/10.1371/journal.pone.0122793
- Koeleman JGM, Stoof J, Biesmans DJ, Savelkoul PH, Vandenbroucke-Grauls CM. 1998. DNA Analysis, and amplified fragment length polymorphism fingerprinting for identification of acinetobacter gnomic species and typing of Acinetobacter baumannii. J. Clin. Microbiol. 36: 2522-2529. https://doi.org/10.1128/JCM.36.9.2522-2529.1998